New candidates in Zealand’s peptide pipeline

Danish biotech company Zealand Pharma’s pipeline contains several research projects including a phase I obesity candidate that, in the preclinical version, proved more effective than one of Novo’s drugs. Zealand is also turning to another Danish company’s preserves.

Photo: Zealand Pharma PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles